President Biden announced he would bring back the Cancer Moonshot initiative that launched in the Obama administration; the World Health Organization said the Omicron subvariant, BA.2, appears to have the same severity as the original Omicron variant; cases of suicide by drug overdose increased in young people, older adults, and non-Hispanic Black women.
President Biden announced Wednesday a plan to reduce the cancer death rate by at least 50% over the next 25 years as part of his Cancer Moonshot initiative, which initially began when he was vice president in the Obama administration. The reinvigorated plan will include a campaign encouraging Americans to get screened for cancer and make up for appointments missed due to the COVID-19 pandemic. According to the American Cancer Society, an estimated 1.9 million new cancer cases and nearly 610,000 cancer deaths are expected in 2022.
As reported by Reuters, the World Health Organization (WHO) stated that the emerging subvariant of Omicron, BA.2, appears to have the same severity as the original Omicron variant, BA.1. WHO also said vaccine efficacy is similar for both the BA.1 and BA.2 viruses, however, the new subvariant has the potential to replace BA.1 globally. These findings are based on data from Denmark that showed BA.2 is more transmissible, even leading to breakthrough cases among vaccinated people, and becoming more dominant in Denmark, the Philippines, Nepal, Qatar, and India.
A study led by researchers at the National Institute on Drug Abuse (NIDA) found that, despite an overall downward trend in the United States, cases of suicide by drug overdose increased in young people aged 15 to 24, older adults aged 75 to 84, and non-Hispanic Black women in 2019. The National Institutes of Health statement said that women were overall more likely to die from intentional drug overdose than men, with the highest cases among women aged 45 to 64. These deaths also varied by time of week or year, with most intentional overdose deaths occurring on Mondays or in spring and summer, and the least deaths occurring on weekends or in December.
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Research Shows Prior Authorization Denials Delay Critical Immunology Care
May 10th 2024Results featured at the Academy of Managed Care Pharmacy 2024 annual meeting revealed a pattern of prior authorization rejections that could delay necessary therapeutic treatments for various patient groups.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Patients With Advanced, Recurrent Melanoma May Experience Lasting AEs From ICM Therapy
May 9th 2024A cross-sectional, mixed-methods study found that adverse effects (AEs) can occur even after 1 year of treatment with immune checkpoint modulator (ICM) therapy in patients with melanoma.
Read More